about
Chordoma: natural history and results in 28 patients treated at a single institution.Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapySpontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought.Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group.Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk.Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients.Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution.Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST).Alveolar soft part sarcoma: clinical presentation, treatment, and outcome in a series of 33 patients at a single institution.Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.Atypical pleomorphic epithelioid angiomyolipoma localized to the pelvis: a case report and review of the literature.Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?Soft-tissue sarcomas of the extremities in patients of pediatric age.Hyperthermia as an adjunctive treatment for soft-tissue sarcoma.Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG.Personalizing surgical margins in retroperitoneal sarcomas.Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.The management of soft tissue tumours of the abdominal wall.Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.Desmoid-Type Fibromatosis: Evolving Treatment Standards.Renal angiomyolipomas: At least two diseases. A series of patients treated at two European institutions.Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment.Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.The symptom interval in children and adolescents with soft tissue sarcomas.External validation of a multi-institutional retroperitoneal sarcoma nomogram.Morcellator's Port-site Metastasis of a Uterine Smooth Muscle Tumor of Uncertain Malignant Potential After Minimally Invasive Myomectomy.Long-term morbidity after multivisceral resection for retroperitoneal sarcoma.Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma.Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue.Correlation between radiological assessment and histopathological diagnosis in retroperitoneal tumors: analysis of 291 consecutive patients at a tertiary reference sarcoma center.Aggressive fibromatosis in children and adolescents: the Italian experience.The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution.Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST.Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma.Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall.Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas.
P50
Q33271347-E1AC43D1-8913-4238-9D5C-3DDAFE12D59FQ33416940-835B2CE7-1676-4F3F-8254-545C1AF40095Q34038265-64120D7D-5863-4AF2-AB3D-7AAB9D6B7D2EQ34039279-E7AEB93D-AF28-4B2B-B3B2-677A747F47EEQ34039708-C42D35E5-1E3B-40A3-A493-F23A0E2FA3D5Q34042707-A341F62C-A2EC-44D8-8F31-3887F3F3C661Q34532365-349F726D-D48A-4A91-A85C-38FC64CD8CE6Q34579626-A4762A79-1384-4257-9748-CCB5D2597A6CQ34602457-A7B7760B-CE73-413C-9CAC-7EEA74309780Q34621104-38AB20E0-F376-4D40-ACB6-84A0C63C1B00Q35214578-842334D2-C644-4DC5-B15A-7ED0D025640AQ35676992-552497A5-5356-4E7E-8E29-95C03F670519Q36970527-7E2CCE75-067D-4D39-AD93-05F649E84302Q37130948-D278E89B-50EC-4631-B43D-B8D9C52BE833Q37385380-6374C511-CA3C-45CC-9A3A-34DD7C29868EQ38000072-C451CF7D-356E-49F1-B26B-D30D4035CAADQ38386811-98AC3137-C1C7-44A9-B43B-DF0046553AC7Q38432012-75E08217-6F0A-46A7-AFA6-67AD62972C0DQ38433512-D5C0E642-F290-4572-85F8-61A6B7B68870Q38772419-EB3615E1-F96D-48F0-B1B8-518063D312D3Q38836706-EC9830EE-438A-498F-AD8F-7EDA9BBAB364Q38945559-3BACCA1F-D331-4287-A6C4-9468326002DFQ39071134-8A26C026-4F4F-4E27-A508-ABF86401081FQ39180339-A2D0E474-A698-4415-BA20-C9918F9AB45CQ39409643-83868A19-4E8D-4B32-9481-2ECC6E02940EQ39858688-2E07E115-746F-4B78-9FB4-497E8F0352FFQ39934939-E02FA09E-AF17-4296-921C-81BD3DD5C1D7Q39967615-BD864844-3A98-4430-9E3D-A206A21929C3Q40018705-37178D75-7B12-40EE-AD0F-7C25341B1C2EQ40871123-258C7383-7562-4857-B158-500335C186A9Q41002971-6BC30515-0F3D-415D-93A8-E8C30627381BQ41501364-FB2D121C-7F9E-45BC-865D-405B421D5B0AQ41694275-2864525F-2F7B-49B3-BAF5-B5FB82D7B441Q41749275-F528D7B5-EF74-4769-843D-244327288A9CQ43233269-C97D3D4F-1C5A-493C-A4F5-780E3CBF927AQ43413868-C75DE85F-6E96-4740-81D5-FD1F03EA0E97Q43680378-2F21E463-E267-4A9C-A2D2-1EE97B2A066CQ43854337-C0EE71A9-C31A-4FFF-8B97-FBC334D4A845Q44382222-5B78E680-5CA1-408A-8B90-D622BAECC413Q44410669-69A65A89-93D5-4FB3-BF07-481F0A2486B2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marco Fiore
@ast
Marco Fiore
@en
Marco Fiore
@es
Marco Fiore
@nl
Marco Fiore
@sl
type
label
Marco Fiore
@ast
Marco Fiore
@en
Marco Fiore
@es
Marco Fiore
@nl
Marco Fiore
@sl
prefLabel
Marco Fiore
@ast
Marco Fiore
@en
Marco Fiore
@es
Marco Fiore
@nl
Marco Fiore
@sl
P1053
M-6587-2016
P106
P1153
7102171752
P21
P31
P3829
P496
0000-0001-8220-424X